As is always the case, I had to cut a slew of choice details out of my latest Wired story—the bizarre and alarming tale of a Washington State clinical-trials company that (and this is the vastest of understatements) didn’t play by the industry’s rules. In a lot of instances, material got left on the cutting-room […]
